Novartis agrees to acquire Avidity Biosciences, an innovator in …
19 hours ago · Basel, October 26, 2025 – Novartis today announced that it has entered into an agreement to acquire Avidity Biosciences, Inc. (Nasdaq: RNA), a San Diego-based, …
Avidity Biosciences Enters into Agreement to be Acquired by Novartis …
19 hours ago · Novartis to acquire Avidity for USD 72.00 per share in cash for total equity value of approximately USD 12.0 billion Avidity expects to separate its...
Novartis agrees to buy Avidity Biosciences for $12bn
12 hours ago · Novartis has signed an agreement for the acquisition of all the outstanding shares of US-based Avidity Biosciences.
Novartis acquiring US firm Avidity Biosciences for $12 bn
2 hours ago · Swiss pharmaceutical giant Novartis announced Sunday it had agreed to buy Avidity Biosciences, valuing the US biopharmaceutical company at $12 billion.
Novartis to acquire Avidity Biosciences for about $12 billion
19 hours ago · Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in cash.
Novartis to buy Avidity Biosciences for $12bn - Financial Times
19 hours ago · Novartis has agreed to buy Avidity Biosciences, a biotech focused on rare diseases, for $12bn, in the biggest acquisition by the drugmaker in more than a decade.
Novartis Agrees to Buy Avidity Biosciences in $12 Billion Deal
19 hours ago · Novartis AG agreed to buy biotechnology company Avidity Biosciences Inc. in a deal that values it at $12 billion, according to the Swiss drugmaker.
Novartis Avidity Biosciences in talks - CNBC
19 hours ago · Swiss pharmaceutical giant Novartis has agreed to buy biotechnology company Avidity Biosciences for about $12 billion, the company said Sunday.
Novartis agrees to acquire Avidity Biosciences, an
19 hours ago · Basel, October 26, 2025 – Novartis today announced that it has entered into an agreement to acquire Avidity Biosciences, Inc. (Nasdaq: RNA), a San Diego-based, …
Novartis Agrees to Acquire Avidity Biosciences for $12 Billion
14 hours ago · Novartis NOVN-1.19%decrease; red down pointing triangle is acquiring Avidity Biosciences RNA 1.24%increase; green up pointing triangle in a $12 billion deal that the Swiss …